Since 2003, Blue November or more commonly known as Movember has been observed each November to raise awareness about men’s health, with a particular focus on testicular and prostate cancer. Prostate cancer is the second most common cancer in men, following lung cancer.
According to Assoc. Dr. Samed Jagodić, Head of the Clinic for Urology, prostate cancer is a malignant tumor that exhibits significant geographical and racial differences in prevalence. It also demonstrates unique dynamics in incidence and mortality rates, with notable advancements in modern diagnostics and treatment leading to improved outcomes.
“Prostate cancer is a significant health concern across the developed world. Each year, the number of prostate cancer diagnoses increases in nearly every country,” stated Assoc. Prof. Jagodić. “The disease predominantly affects men over 50, often resulting in substantial morbidity and mortality. Early detection, particularly of prostate and testicular cancers, is crucial, as diagnosing cancer at an earlier stage significantly improves treatment outcomes.”
Assoc. Prof. Jagodić emphasized the importance of prevention and encouraged all men over 50, as well as those with a family history of the disease, to undergo a PSA test. He also urged them to schedule a consultation with a urologist for a digital rectal examination of the prostate and an ultrasound evaluation of the urinary tract.
“Take advantage of the opportunity for early diagnosis! Detecting prostate changes early significantly improves the chances of a cure,” said Assoc. Prof. Samed Jagodić. “With appropriate therapy, issues related to benign prostate enlargement can be effectively managed, leading to improved health and a better quality of life. Early detection of prostate cancer greatly increases the likelihood of successful treatment.”
